Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial Infarction.

The International journal of angiology : official publication of the International College of Angiology, Inc

Dharma S, Hapsari R, Siswanto BB, van der Laarse A, Jukema JW.
PMID: 26060384
Int J Angiol. 2015 Jun;24(2):127-32. doi: 10.1055/s-0035-1544178.

We aim to test the hypothesis that blood leukocyte count adds prognostic information in patients with acute non-ST-elevation myocardial infarction (non-STEMI). A total of 585 patients with acute non-STEMI (thrombolysis in myocardial infarction risk score ≥ 3) were enrolled...

Cite
Dharma S, Hapsari R, Siswanto BB, et al. Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial Infarction. Int J Angiol. 2015;24(2):127-32doi: 10.1055/s-0035-1544178.
Dharma, S., Hapsari, R., Siswanto, B. B., van der Laarse, A., & Jukema, J. W. (2015). Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial Infarction. The International journal of angiology : official publication of the International College of Angiology, Inc, 24(2), 127-32. https://doi.org/10.1055/s-0035-1544178
Dharma, Surya, et al. "Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial Infarction." The International journal of angiology : official publication of the International College of Angiology, Inc vol. 24,2 (2015): 127-32. doi: https://doi.org/10.1055/s-0035-1544178
Dharma S, Hapsari R, Siswanto BB, van der Laarse A, Jukema JW. Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial Infarction. Int J Angiol. 2015 Jun;24(2):127-32. doi: 10.1055/s-0035-1544178. PMID: 26060384; PMCID: PMC4452600.
Copy Download .nbib Format: NLM
The quest for an atrium-specific biomarker.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van der Laarse A, de Vries AA.
PMID: 21475408
Neth Heart J. 2011 Mar;19(3):151-152. doi: 10.1007/s12471-011-0082-8. Epub 2011 Feb 12.

No abstract available.

Cite
van der Laarse A, de Vries AA. The quest for an atrium-specific biomarker. Neth Heart J. 2011;19(3):151-152doi: 10.1007/s12471-011-0082-8.
van der Laarse, A., & de Vries, A. A. (2011). The quest for an atrium-specific biomarker. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 19(3), 151-152. https://doi.org/10.1007/s12471-011-0082-8
van der Laarse, A, and de Vries, A A F. "The quest for an atrium-specific biomarker." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 19,3 (2011): 151-152. doi: https://doi.org/10.1007/s12471-011-0082-8
van der Laarse A, de Vries AA. The quest for an atrium-specific biomarker. Neth Heart J. 2011 Mar;19(3):151-152. doi: 10.1007/s12471-011-0082-8. Epub 2011 Feb 12. PMID: 21475408; PMCID: PMC3047704.
Copy Download .nbib Format: NLM
Metabolic Cost of Activation and Mechanical Efficiency of Mouse Soleus Muscle Fiber Bundles During Repetitive Concentric and Eccentric Contractions.

Frontiers in physiology

Lemaire KK, Jaspers RT, Kistemaker DA, van Soest AJK, van der Laarse WJ.
PMID: 31293438
Front Physiol. 2019 Jun 21;10:760. doi: 10.3389/fphys.2019.00760. eCollection 2019.

Currently available data on the energetics of isolated muscle preparations are based on bouts of less than 10 muscle contractions, whereas metabolic energy consumption is mostly relevant during steady state tasks such as locomotion. In this study we quantified...

Cite
Lemaire KK, Jaspers RT, Kistemaker DA, et al. Metabolic Cost of Activation and Mechanical Efficiency of Mouse Soleus Muscle Fiber Bundles During Repetitive Concentric and Eccentric Contractions. Front Physiol. 2019;10:760doi: 10.3389/fphys.2019.00760.
Lemaire, K. K., Jaspers, R. T., Kistemaker, D. A., van Soest, A. J. K., & van der Laarse, W. J. (2019). Metabolic Cost of Activation and Mechanical Efficiency of Mouse Soleus Muscle Fiber Bundles During Repetitive Concentric and Eccentric Contractions. Frontiers in physiology, 10760. https://doi.org/10.3389/fphys.2019.00760
Lemaire, Koen K, et al. "Metabolic Cost of Activation and Mechanical Efficiency of Mouse Soleus Muscle Fiber Bundles During Repetitive Concentric and Eccentric Contractions." Frontiers in physiology vol. 10 (2019): 760. doi: https://doi.org/10.3389/fphys.2019.00760
Lemaire KK, Jaspers RT, Kistemaker DA, van Soest AJK, van der Laarse WJ. Metabolic Cost of Activation and Mechanical Efficiency of Mouse Soleus Muscle Fiber Bundles During Repetitive Concentric and Eccentric Contractions. Front Physiol. 2019 Jun 21;10:760. doi: 10.3389/fphys.2019.00760. eCollection 2019. PMID: 31293438; PMCID: PMC6599155.
Copy Download .nbib Format: NLM
Genetic programme of cardiogenesis: implications for therapeutic application.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van Tuyn J, de Vries AA, van der Laarse A, Schalij MJ, van der Wall EE, Atsma DE.
PMID: 25696254
Neth Heart J. 2004 Jan;12(1):13-17.

It has become accepted that new cardiomyocytes can be derived from stem cells. Although the potential for therapeutic application is evident, the reported efficiency of differentiation varies greatly from 0.02 to 54%. To obtain clinically relevant numbers of newly...

Cite
van Tuyn J, de Vries AA, van der Laarse A, et al. Genetic programme of cardiogenesis: implications for therapeutic application. Neth Heart J. 2004;12(1):13-17
van Tuyn, J., de Vries, A. A., van der Laarse, A., Schalij, M. J., van der Wall, E. E., & Atsma, D. E. (2004). Genetic programme of cardiogenesis: implications for therapeutic application. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 12(1), 13-17.
van Tuyn, J, et al. "Genetic programme of cardiogenesis: implications for therapeutic application." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 12,1 (2004): 13-17.
van Tuyn J, de Vries AA, van der Laarse A, Schalij MJ, van der Wall EE, Atsma DE. Genetic programme of cardiogenesis: implications for therapeutic application. Neth Heart J. 2004 Jan;12(1):13-17. PMID: 25696254; PMCID: PMC2497038.
Copy Download .nbib Format: NLM
Genetic factors in arrhythmogenic right ventricular cardiomyopathy: need for a DNA bank!.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van der Wall EE, Schalij MJ, van der Laarse A.
PMID: 25696557
Neth Heart J. 2006 Oct;14(10):323-324.

No abstract available.

Cite
van der Wall EE, Schalij MJ, van der Laarse A. Genetic factors in arrhythmogenic right ventricular cardiomyopathy: need for a DNA bank!. Neth Heart J. 2006;14(10):323-324
van der Wall, E. E., Schalij, M. J., & van der Laarse, A. (2006). Genetic factors in arrhythmogenic right ventricular cardiomyopathy: need for a DNA bank!. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 14(10), 323-324.
van der Wall, E E, et al. "Genetic factors in arrhythmogenic right ventricular cardiomyopathy: need for a DNA bank!." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 14,10 (2006): 323-324.
van der Wall EE, Schalij MJ, van der Laarse A. Genetic factors in arrhythmogenic right ventricular cardiomyopathy: need for a DNA bank!. Neth Heart J. 2006 Oct;14(10):323-324. PMID: 25696557; PMCID: PMC2557315.
Copy Download .nbib Format: NLM
Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine.

Expert review of cardiovascular therapy

van der Laarse A, Cobbaert CM.
PMID: 34937476
Expert Rev Cardiovasc Ther. 2022 Jan 03;1-12. doi: 10.1080/14779072.2021.2022475. Epub 2022 Jan 03.

INTRODUCTION: Guidelines of management of dyslipidemias and prevention of cardiovascular disease (CVD) are based on firm scientific evidence obtained by randomized controlled trials (RCTs). However, the role of elevated low-density lipoprotein-cholesterol (LDL-C)as a risk factor of CVD and therapies...

Cite
van der Laarse A, Cobbaert CM. Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine. Expert Rev Cardiovasc Ther. 2022;1-12doi: 10.1080/14779072.2021.2022475.
van der Laarse, A., & Cobbaert, C. M. (2022). Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine. Expert review of cardiovascular therapy, 1-12. https://doi.org/10.1080/14779072.2021.2022475
van der Laarse, Arnoud, and Cobbaert, Christa M. "Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine." Expert review of cardiovascular therapy vol. (2022): 1-12. doi: https://doi.org/10.1080/14779072.2021.2022475
van der Laarse A, Cobbaert CM. Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine. Expert Rev Cardiovasc Ther. 2022 Jan 03;1-12. doi: 10.1080/14779072.2021.2022475. Epub 2022 Jan 03. PMID: 34937476.
Copy Download .nbib Format: NLM
Oxygen uptake in heart failure: how much, how fast?.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

Gademan MG, van der Laarse A, Swenne CA, van der Wall EE.
PMID: 19789683
Neth Heart J. 2009 Jun;17(6):224-5. doi: 10.1007/BF03086251.

No abstract available.

Cite
Gademan MG, van der Laarse A, Swenne CA, et al. Oxygen uptake in heart failure: how much, how fast?. Neth Heart J. 2009;17(6):224-5doi: 10.1007/BF03086251.
Gademan, M. G., van der Laarse, A., Swenne, C. A., & van der Wall, E. E. (2009). Oxygen uptake in heart failure: how much, how fast?. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 17(6), 224-5. https://doi.org/10.1007/BF03086251
Gademan, M G J, et al. "Oxygen uptake in heart failure: how much, how fast?." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 17,6 (2009): 224-5. doi: https://doi.org/10.1007/BF03086251
Gademan MG, van der Laarse A, Swenne CA, van der Wall EE. Oxygen uptake in heart failure: how much, how fast?. Neth Heart J. 2009 Jun;17(6):224-5. doi: 10.1007/BF03086251. PMID: 19789683; PMCID: PMC2711246.
Copy Download .nbib Format: NLM
Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency.

Pulmonary circulation

Ruiter G, Manders E, Happé CM, Schalij I, Groepenhoff H, Howard LS, Wilkins MR, Bogaard HJ, Westerhof N, van der Laarse WJ, de Man FS, Vonk-Noordegraaf A.
PMID: 26401247
Pulm Circ. 2015 Sep;5(3):466-72. doi: 10.1086/682217.

UNLABELLED: In patients with idiopathic pulmonary arterial hypertension (iPAH), iron deficiency is common and has been associated with reduced exercise capacity and worse survival. Previous studies have shown beneficial effects of intravenous iron administration. In this study, we investigated...

Cite
Ruiter G, Manders E, Happé CM, et al. Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulm Circ. 2015;5(3):466-72doi: 10.1086/682217.
Ruiter, G., Manders, E., Happé, C. M., Schalij, I., Groepenhoff, H., Howard, L. S., Wilkins, M. R., Bogaard, H. J., Westerhof, N., van der Laarse, W. J., de Man, F. S., & Vonk-Noordegraaf, A. (2015). Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulmonary circulation, 5(3), 466-72. https://doi.org/10.1086/682217
Ruiter, Gerrina, et al. "Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency." Pulmonary circulation vol. 5,3 (2015): 466-72. doi: https://doi.org/10.1086/682217
Ruiter G, Manders E, Happé CM, Schalij I, Groepenhoff H, Howard LS, Wilkins MR, Bogaard HJ, Westerhof N, van der Laarse WJ, de Man FS, Vonk-Noordegraaf A. Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulm Circ. 2015 Sep;5(3):466-72. doi: 10.1086/682217. PMID: 26401247; PMCID: PMC4556497.
Copy Download .nbib Format: NLM
Increased oxidative metabolism and myoglobin expression in zebrafish muscle during chronic hypoxia.

Biology open

Jaspers RT, Testerink J, Della Gaspera B, Chanoine C, Bagowski CP, van der Laarse WJ.
PMID: 25063194
Biol Open. 2014 Jul 25;3(8):718-27. doi: 10.1242/bio.20149167.

Fish may be extremely hypoxia resistant. We investigated how muscle fibre size and oxidative capacity in zebrafish (Danio rerio) adapt during severe chronic hypoxia. Zebrafish were kept for either 3 or 6 weeks under chronic constant hypoxia (CCH) (10%...

Cite
Jaspers RT, Testerink J, Della Gaspera B, et al. Increased oxidative metabolism and myoglobin expression in zebrafish muscle during chronic hypoxia. Biol Open. 2014;3(8):718-27doi: 10.1242/bio.20149167.
Jaspers, R. T., Testerink, J., Della Gaspera, B., Chanoine, C., Bagowski, C. P., & van der Laarse, W. J. (2014). Increased oxidative metabolism and myoglobin expression in zebrafish muscle during chronic hypoxia. Biology open, 3(8), 718-27. https://doi.org/10.1242/bio.20149167
Jaspers, Richard T, et al. "Increased oxidative metabolism and myoglobin expression in zebrafish muscle during chronic hypoxia." Biology open vol. 3,8 (2014): 718-27. doi: https://doi.org/10.1242/bio.20149167
Jaspers RT, Testerink J, Della Gaspera B, Chanoine C, Bagowski CP, van der Laarse WJ. Increased oxidative metabolism and myoglobin expression in zebrafish muscle during chronic hypoxia. Biol Open. 2014 Jul 25;3(8):718-27. doi: 10.1242/bio.20149167. PMID: 25063194; PMCID: PMC4133725.
Copy Download .nbib Format: NLM
Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk.

Clinical epidemiology

Orsi FA, Lijfering WM, Van der Laarse A, Ruhaak LR, Rosendaal FR, Cannegieter SC, Cobbaert C.
PMID: 31413640
Clin Epidemiol. 2019 Jul 22;11:625-633. doi: 10.2147/CLEP.S196266. eCollection 2019.

PURPOSE: Apolipoproteins C-I, C-II, C-III and E have been associated with risk of arterial thrombotic diseases. We investigated whether these apolipoproteins have prothrombotic properties and are associated with risk of venous thromboembolism (VTE).PATIENTS AND METHODS: A total of 127...

Cite
Orsi FA, Lijfering WM, Van der Laarse A, et al. Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk. Clin Epidemiol. 2019;11:625-633doi: 10.2147/CLEP.S196266.
Orsi, F. A., Lijfering, W. M., Van der Laarse, A., Ruhaak, L. R., Rosendaal, F. R., Cannegieter, S. C., & Cobbaert, C. (2019). Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk. Clinical epidemiology, 11625-633. https://doi.org/10.2147/CLEP.S196266
Orsi, Fernanda A, et al. "Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk." Clinical epidemiology vol. 11 (2019): 625-633. doi: https://doi.org/10.2147/CLEP.S196266
Orsi FA, Lijfering WM, Van der Laarse A, Ruhaak LR, Rosendaal FR, Cannegieter SC, Cobbaert C. Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk. Clin Epidemiol. 2019 Jul 22;11:625-633. doi: 10.2147/CLEP.S196266. eCollection 2019. PMID: 31413640; PMCID: PMC6659780.
Copy Download .nbib Format: NLM
Evaluation of antiatherosclerotic drugs by Raman spectroscopy.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

van de Poll SW, van der Laarse A.
PMID: 25696145
Neth Heart J. 2003 Jan;11(1):47-50.

No abstract available.

Cite
van de Poll SW, van der Laarse A. Evaluation of antiatherosclerotic drugs by Raman spectroscopy. Neth Heart J. 2003;11(1):47-50
van de Poll, S. W., & van der Laarse, A. (2003). Evaluation of antiatherosclerotic drugs by Raman spectroscopy. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 11(1), 47-50.
van de Poll, S W F, and van der Laarse, A. "Evaluation of antiatherosclerotic drugs by Raman spectroscopy." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 11,1 (2003): 47-50.
van de Poll SW, van der Laarse A. Evaluation of antiatherosclerotic drugs by Raman spectroscopy. Neth Heart J. 2003 Jan;11(1):47-50. PMID: 25696145; PMCID: PMC2499835.
Copy Download .nbib Format: NLM
Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine.

Expert review of cardiovascular therapy

van der Laarse A, Cobbaert CM.
PMID: 34937476
Expert Rev Cardiovasc Ther. 2021 Dec 23; doi: 10.1080/14779072.2021.2022475. Epub 2021 Dec 23.

INTRODUCTION: The guidelines of management of dyslipidemias and prevention of cardiovascular disease (CVD) are based on firm scientific evidence obtained by randomized controlled trials (RCTs). However, the role of elevated low-density lipoprotein-cholesterol (LDL-C) level as a risk factor of...

Cite
van der Laarse A, Cobbaert CM. Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine. Expert Rev Cardiovasc Ther. 2021;doi: 10.1080/14779072.2021.2022475.
van der Laarse, A., & Cobbaert, C. M. (2021). Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine. Expert review of cardiovascular therapy, . https://doi.org/10.1080/14779072.2021.2022475
van der Laarse, Arnoud, and Cobbaert, Christa M. "Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine." Expert review of cardiovascular therapy vol. (2021). doi: https://doi.org/10.1080/14779072.2021.2022475
van der Laarse A, Cobbaert CM. Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine. Expert Rev Cardiovasc Ther. 2021 Dec 23; doi: 10.1080/14779072.2021.2022475. Epub 2021 Dec 23. PMID: 34937476.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries